|
|
Volumn 23, Issue 2, 2009, Pages 153-155
|
|
Buprenorphine for opioid dependence
a
|
|
Author keywords
Addiction; Buprenorphine; Dependence; Opiate; Opioid
|
|
Indexed keywords
BUPRENORPHINE;
BUPRENORPHINE PLUS NALOXONE;
METHADONE;
NALOXONE;
NARCOTIC ANALGESIC AGENT;
NARCOTIC ANTAGONIST;
ABDOMINAL PAIN;
CENTRAL NERVOUS SYSTEM DEPRESSION;
CONSTIPATION;
CONTINUOUS INFUSION;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDUCED HEADACHE;
DRUG INTOXICATION;
DRUG MARKETING;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG OVERDOSE;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG USE;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
HEALTH CENTER;
HUMAN;
IMMUNOASSAY;
METHADONE TREATMENT;
NAUSEA;
NOTE;
OPIATE ADDICTION;
RESPIRATION DEPRESSION;
SIDE EFFECT;
SWEATING;
TABLET FORMULATION;
WITHDRAWAL SYNDROME;
INTOXICATION;
PAIN;
REVIEW;
ANALGESICS, OPIOID;
BUPRENORPHINE;
HUMANS;
NARCOTIC ANTAGONISTS;
OPIOID-RELATED DISORDERS;
OVERDOSE;
PAIN;
|
|
EID: 68549096377
PISSN: 15360288
EISSN: 15360539
Source Type: Journal
DOI: 10.1080/15360280902900869 Document Type: Note |
|
Times cited : (5)
|
|
References (8)
|
